Kohei Yamakawa
Overview
Explore the profile of Kohei Yamakawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamakawa K, Kurita Y, Ishikawa H, Aichi M, Fujita S, Hasegawa S, et al.
Clin Nutr ESPEN
. 2025 Feb;
66:474-481.
PMID: 39978729
Background & Aims: Low muscle mass is associated with poor immune checkpoint inhibitor (ICI) efficacy in patients with melanoma; however, whether this is true in all populations remains to be...
2.
Abe S, Masuda A, Matsumoto T, Inoue J, Toyama H, Sakai A, et al.
J Gastroenterol
. 2024 Jan;
59(3):250-262.
PMID: 38242997
Background: Recent evidence suggests that the presence of microbiome within human pancreatic ductal adenocarcinoma (PDAC) tissue potentially influences cancer progression and prognosis. However, the significance of tumor-resident microbiome remains unclear....
3.
Tanaka S, Tsujimae M, Masuda A, Inoue J, Inomata N, Uemura H, et al.
Pancreas
. 2023 Oct;
53(1):e9-e15.
PMID: 37890158
Objectives: Aging is associated with a high prevalence of pancreatic cysts and intraductal papillary mucinous neoplasms (IPMNs). Metabolic syndrome (MS) may increase the risk of neoplasms, including those that develop...
4.
Yamakawa K, Inomata N, Masuda A, Takenaka M, Toyama H, Sofue K, et al.
Sci Rep
. 2023 Jul;
13(1):12052.
PMID: 37491554
Pancreatic cancer primarily arises from microscopic precancerous lesions, such as pancreatic intraepithelial neoplasia (PanIN) and acinar-to-ductal metaplasia (ADM). However, no established method exists for predicting pancreatic precancerous conditions. Endoscopic ultrasonography...
5.
Ashina S, Masuda A, Yamakawa K, Hamada T, Tsujimae M, Tanaka T, et al.
J Gastroenterol
. 2023 Jul;
58(10):1055-1067.
PMID: 37477731
Background: Abundant collagen deposition is a hallmark of pancreatic ductal adenocarcinomas (PDACs). This study clarified the interactive relationship between tumor-stromal collagen, molecular and immune characteristics, and tumor pr ogression in...
6.
Watanabe T, Yoon S, Yamakawa K, Hyodo T, Izaki K, Okada H, et al.
Am J Case Rep
. 2023 Jul;
24:e939614.
PMID: 37391901
BACKGROUND Various neoplasms, including neuroendocrine neoplasms (NENs), can arise from the presacral space. Most presacral lesions are detected due to symptoms arising from tumor growth. However, diagnosing small, asymptomatic presacral...
7.
Gonda M, Kobayashi T, Notohara K, Abe S, Yamakawa K, Sakai A, et al.
Clin J Gastroenterol
. 2023 May;
16(5):785-790.
PMID: 37222917
A 75-year-old Japanese woman visited a hospital with a stomachache. The patient was diagnosed with localized mild acute pancreatitis. Blood tests revealed elevated serum IgG4 levels. Contrast-enhanced computed tomography showed...
8.
Yamakawa K, Koyanagi-Aoi M, Machinaga A, Kakiuchi N, Hirano T, Kodama Y, et al.
Cancer Cell Int
. 2023 May;
23(1):94.
PMID: 37198667
Background: Our study and several studies have reported that in some cancers, including pancreatic ductal adenocarcinoma (PDAC), the expression of squamous lineage markers, such as esophagus-tissue-specific genes, correlated with a...
9.
Masuda S, Yamakawa K, Masuda A, Toyama H, Sofue K, Nanno Y, et al.
Ann Surg Oncol
. 2023 May;
30(9):5776-5787.
PMID: 37191859
Background: Sarcopenia, defined as a loss of skeletal muscle mass and quality, is found in 30-65% of patients with pancreatic ductal adenocarcinoma (PDAC) at diagnosis, and is a poor prognostic...
10.
Masuda S, Yamakawa K, Masuda A
Ann Surg Oncol
. 2023 May;
30(9):5788-5789.
PMID: 37166741
No abstract available.